ZYVERSA THERAPEUTICS, INC. (ZVSA) Operating cash flow 2023–2025
ZYVERSA THERAPEUTICS, INC. (ZVSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.1MFY2025 · since FY2023: -$8.7M → -$5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.1M | +32.0% |
| FY2024 | -$7.5M | +13.8% |
| FY2023 | -$8.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice